Detalhe da pesquisa
1.
Clinical and molecular signature of survival and resistance to olaparib plus pegylated liposomal doxorubicin in platinum-resistant ovarian cancer: a stratified analysis from the phase II clinical trial ROLANDO, GEICO-1601.
Int J Gynecol Cancer
; 33(6): 929-936, 2023 06 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36759001
2.
European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023.
Int J Gynecol Cancer
; 33(7): 1023-1043, 2023 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37369376
3.
Comparison of Methods for Testing Mismatch Repair Status in Endometrial Cancer.
Int J Mol Sci
; 24(19)2023 Sep 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37833916
4.
The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO).
Int J Mol Sci
; 24(13)2023 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37446361
5.
Evaluation of Immune Infiltrates in Ovarian Endometriosis and Endometriosis-Associated Ovarian Cancer: Relationship with Histological and Clinical Features.
Int J Mol Sci
; 24(15)2023 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37569458
6.
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
N Engl J Med
; 381(25): 2391-2402, 2019 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31562799
7.
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.
N Engl J Med
; 380(7): 617-628, 2019 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30516102
8.
Prognostic implications of tumor-infiltrating T cells in early-stage endometrial cancer.
Mod Pathol
; 35(2): 256-265, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34642425
9.
Olaparib as first line in BRCA-mutated advanced ovarian carcinoma: Is it cost-effective in Spain?
Gynecol Oncol
; 164(2): 406-414, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34844775
10.
Design of Ionic Liquids for Fluorinated Gas Absorption: COSMO-RS Selection and Solubility Experiments.
Environ Sci Technol
; 56(9): 5898-5909, 2022 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35435682
11.
Patient-reported outcomes in the GARNET trial in patients with advanced or recurrent mismatch repair-deficient/microsatellite instability-high endometrial cancer treated with dostarlimab.
Int J Gynecol Cancer
; 2022 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35973737
12.
Prognostic markers of inflammation in endometrioid and clear cell ovarian cancer.
Int J Gynecol Cancer
; 32(8): 1009-1016, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35437272
13.
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study.
Lancet Oncol
; 22(5): 609-619, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33845034
14.
Eribulin activity in soft tissue sarcoma monolayer and three-dimensional cell line models: could the combination with other drugs improve its antitumoral effect?
Cancer Cell Int
; 21(1): 646, 2021 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34863177
15.
Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 21(3): 456-466, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32066540
16.
Patient-reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for human epidermal growth factor receptor 2-positive breast cancer.
Cancer
; 126(13): 3132-3139, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32286687
17.
Are antiangiogenics a good 'partner' for immunotherapy in ovarian cancer?
Angiogenesis
; 23(4): 543-557, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32691290
18.
Primary results from CECILIA, a global single-arm phase II study evaluating bevacizumab, carboplatin and paclitaxel for advanced cervical cancer.
Gynecol Oncol
; 159(1): 142-149, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32763109
19.
Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer - a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34).
Int J Gynecol Cancer
; 30(12): 1997-2001, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32606097
20.
Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 20(9): 1252-1262, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31331701